Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03626194 · ClinicalTrials.gov registry record
Prospective Evaluation of the Efficacy and Safety of Endoscopic Tissue Apposition
A clinical trial of Endoscopic Sleeve Gastroplasty and Endoscopic Tissue Apposition, sponsored by University of Colorado, Denver.
- Recruiting
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT03626194: Recruiting study of Endoscopic Sleeve Gastroplasty and Endoscopic Tissue Apposition, sponsored by University of Colorado, Denver.
NCT03626194 is a study of Endoscopic Sleeve Gastroplasty and Endoscopic Tissue Apposition that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 500 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03626194, a study of Endoscopic Sleeve Gastroplasty and Endoscopic Tissue Apposition, is actively recruiting participants, sponsored by University of Colorado, Denver.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a prospective registry of patients undergoing endoscopic suturing and/or clip placement at our institution to assess the efficacy and safety of endoscopic tissue apposition. 1.1 Hypothesis: Endoscopic tissue apposition is efficacious and safe in the practice of gastrointestinal endoscopy. 1.2 Aims: To prospectively evaluate the efficacy and safety of Endoscopic Tissue Apposition in the practice of gastrointestinal endoscopy.
Primary Outcome
Successful completion of endoscopic suturing/clipping and measured as clinical symptom improvement as well as objective evidence of resolution / improvement of underlying pathology / confirmed with radiologic contrast studies as needed..
Conditions Studied
Study Locations (1)
Colorado
- University of Colorado Hospital - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2016-12-12 |
| Est. Completion | 2026-12-16 |
What NCT03626194 shows while recruiting
NCT03626194 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap.
The record links to 6 conditions, with Endoscopic Sleeve Gastroplasty appearing as the primary indexed condition, and to 0 interventions.
NCT03626194 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT03626194 about?
NCT03626194 is a clinical study titled "Prospective Evaluation of the Efficacy and Safety of Endoscopic Tissue Apposition". This study is a prospective registry of patients undergoing endoscopic suturing and/or clip placement at our institution to assess the efficacy and safety of endoscopic tissue apposition. 1.1 Hypothesis: Endoscopic tissue apposition is efficacious and safe in the practice of gastrointestinal endosc...
What is the current status of trial NCT03626194?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2016-12-12. Estimated completion is 2026-12-16.
What conditions does trial NCT03626194 study?
This clinical trial studies the following conditions: Endoscopic Sleeve Gastroplasty, Endoscopic Tissue Apposition, Endoscopic Suturing, Endoscopic Clipping, Bariatric Endoscopy.
Who is sponsoring clinical trial NCT03626194?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03626194 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Endoscopic Sleeve Gastroplasty
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI